Clinical Trial Update: A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating sedation using HSK3486 in ICU patients on long-term mechanical ventilation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness Sedation
• Intensive Care Unit Sedation

Drugs mentioned

• HSK3486 (HSK3486)

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Sedation in Intensive Care | Phase 2 | Status: COMPLETED